Antidepressants induce profibrotic responses via the lysophosphatidic acid receptor LPA1
- 1 April 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 873, 172963
Abstract
No abstract availableKeywords
Funding Information
- University of Cagliari (FIR 2018)
This publication has 55 references indexed in Scilit:
- Amitriptyline aggravates the fibrosis process in a rat model of infravesical obstructionInternational Journal of Experimental Pathology, 2012
- Recent Developments in Myofibroblast BiologyThe American Journal of Pathology, 2012
- Platelet-derived serotonin links vascular disease and tissue fibrosisJournal of Experimental Medicine, 2011
- Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of sclerodermaArthritis & Rheumatism, 2011
- Aiming drug discovery at lysophosphatidic acid targetsBritish Journal of Pharmacology, 2010
- A novel, orally active LPA 1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin modelBritish Journal of Pharmacology, 2010
- Pulmonary fibrosis associated with psychotropic drug therapy: a case reportJournal of Medical Case Reports, 2009
- Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA6Journal of Biological Chemistry, 2009
- The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transitionOncogene, 2007
- A Role for Serotonin (5-HT) in Hepatic Stellate Cell Function and Liver FibrosisThe American Journal of Pathology, 2006